METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Metoprolol Tartrate And Hydrochlorothiazide patents expire, and when can generic versions of Metoprolol Tartrate And Hydrochlorothiazide launch?
Metoprolol Tartrate And Hydrochlorothiazide is a drug marketed by Alembic, Mylan, and Sun Pharm Inds. and is included in three NDAs.
The generic ingredient in METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE?
Summary for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 4 |
| Clinical Trials: | 3 |
| DailyMed Link: | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mylan Pharmaceuticals | Phase 1 |
| Vanderbilt University | Phase 1 |
| Vanderbilt University Medical Center | Phase 1 |
See all METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
| Drug Class | Thiazide Diuretic beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 202870-001 | Nov 6, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 090654-001 | Jan 19, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 076792-001 | Aug 20, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
